Short-term effects of parathyroid hormone on rat lumbar vertebrae

Spine

Volumn 34, Issue 19, 2009, Pages 2014-2021

  Sehmisch, Stephan ^a   Erren, Matthias ^a   Rack, Thomas ^a   Tezval, Mohammed ^a   Seidlova Wuttke, Dana ^a   Richter, Julia ^b   Wuttke, Wolfgang ^a   Stuermer, Klaus M ^a   Stuermer, Ewa K ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Spine Center   (Germany)

Author keywords

Biomechanical compression test; Bone microstructure; Osteoporosis; Parathyroid hormone

Indexed keywords

ESTRADIOL BENZOATE; OSTEOCALCIN; PARATHYROID HORMONE[1-34];

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BODY WEIGHT; BONE STRUCTURE; COMPRESSIVE STRENGTH; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONAL THERAPY; LUMBAR VERTEBRA; MICRORADIOGRAPHY; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; TRABECULAR BONE; VERTEBRA BODY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL MARKERS; BIOMECHANICS; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; COMPRESSIVE STRENGTH; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; INJECTIONS, SUBCUTANEOUS; LUMBAR VERTEBRAE; MICRORADIOGRAPHY; OSTEOCALCIN; OSTEOPOROSIS; OVARIECTOMY; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 70349091069     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181afe846     Document Type: Article

References (24)

1. Siris E, Adachi JD, Lu Y, et al. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple outcomes of raloxifene evaluation. Osteoporos Int 2002; 13:907-913
2. Lindsay R, Gallagher JC, Kleerekoper M, et al. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyproges-terone acetate in early postmenopausal women. Osteoporos Int 2005;16: 372-379
3. Genant HK, Delmas PD, Chen P, et al. Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int 2007;18:69-76.
4. Thompson DD, Simmons HA, Pirie CM, et al. FDA Guidelines and animal models for osteoporosis. Bone 1995;17:125-133
5. Wronski TJ, Lowry PL, Walsh CC, et al. Skeletal alterations in ovariecto-mized rats. Calcif Tissue Int 1985;37:324-328
6. Partridge NC, Li X, Qin L. Understanding parathyroid hormone action. Ann N Y Acad 2006;1068:187-193
7. Ejersted C, Andreassen TT, Nilsson MH, et al. Human parathyroid hormone (1-34) increases bone formation and strength of cortical bone in aged rats. Eur J Endocrinol 1994;130:201-207
8. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-1441
9. Deal C, Omizo M, Schwartz EN, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial. J Bone Miner Res 2005;20:1905-1911
10. Sato M, Vahle J, Schmidt A, et al. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH. Endocrinology 2002;143:3230-3242
11. Sato M, Ma EL, Hock JM, et al. Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment. J Pharmacol Exp Ther 2002;302:304-313
12. Reeve J, Meunier PJ, Parsons JA, et al. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. BMJ 1980;7:280:1340-1344
13. Ikeda S, Tsurukami H, Ito M, et al. Effect of trabecular bone contour on ultimate strength of lumbar vertebra after bilateral ovariectomy in rats. Bone 2001;28:625-633
14. Liang L, Jiang Z, Liu Z, et al. Clinical observation on osteoporosis treated with traditional kidney-tonifying medicaments. J Tradit Chin Med 1994;14: 41-44
15. Sturmer EK, Seidlova-Wuttke D, Sehmisch S, et al. Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibia of the rat: effect of estradiol, testosterone, and raloxifene. J Bone Miner Res 2006;21: 89-96.
16. Sturmer KM. Mikroradiographie des knochens, technik, aussagekraft und planimetrie. Hefte Unfallheilk 1980;148:247-251
17. Parfitt AM, Drezner MK, Gloriex FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987;2: 595-610.
18. Arita S, Ikeda S, Sakai A, et al. Human parathyroid hormone (1-34) increases mass and structure of the cortical shell, with resultant increase in lumbar bone strength, in ovariectomized rats. J Bone Miner Metab 2004;22: 530-540
19. Dempster DW, Cosman F, Kurland ES, et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 2001;16:1846-1853
20. Hodsman AB, Kisiel M, Adachi JD, et al. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH (1-34) therapy in women with severe osteoporosis. Bone 2000;27:311-318
21. Fisk JW, Baigent ML. Clinical and radiological assessment of leg length. N Z Med J 1975;81:477-480
22. Heufelder P. The leg length-difference. Statistics of a general practice. Examinations since 1976. Z Orthop 1981;119:469-474
23. Neumann S. Handedness in comparison with the asymmetry of the upper extremities. Z Morphol Anthropol 1992;79:183-195
24. Budsberg SC, Jevens DJ, Brown J, et al. Evaluation of limb symmetry indices, using ground reaction forces in healthy dogs. Am J Vet Res 1993;54:1569-1574